2006
DOI: 10.1111/j.1464-5491.2006.01855.x
|View full text |Cite
|
Sign up to set email alerts
|

Diabetes with partial lipodystrophy following sclerodermatous chronic graft vs. host disease

Abstract: However, although thiazolidinediones lower insulin resistance and increase subcutaneous peripheral fat in Type 2 diabetes, pioglitazone treatment had little effect on either serum adiponectin, glycaemic control or the lipoatrophy. In this case, effective glycaemic control was best achieved using a combination of metformin and highly concentrated soluble insulin injections.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

3
27
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 31 publications
(30 citation statements)
references
References 15 publications
(19 reference statements)
3
27
0
Order By: Relevance
“…Consistent with this, in our six patients with lipodystrophy, > 9 yr had elapsed since the initial HSCT. This observation is in accordance with previous reports, in which almost a decade was necessary for either lipodystrophy or diabetes to develop following HSCT (9, 10, 12,13,14). …”
Section: Discussionsupporting
confidence: 93%
See 3 more Smart Citations
“…Consistent with this, in our six patients with lipodystrophy, > 9 yr had elapsed since the initial HSCT. This observation is in accordance with previous reports, in which almost a decade was necessary for either lipodystrophy or diabetes to develop following HSCT (9, 10, 12,13,14). …”
Section: Discussionsupporting
confidence: 93%
“…In previous reports of HSCT-related lipodystrophy (9, 10, 12, 14), including our study (13), all patients had undergone TBI. Mayson et al .…”
Section: Discussionmentioning
confidence: 88%
See 2 more Smart Citations
“…Each year a variety of medical procedures are required for the repair of adipose tissue traumas and abnormalities, including breast reconstructions following mastectomies [1], cosmetic facial reconstructions of the cheek, chin, and jaw [2,3], and lipodystrophies associated with type II diabetes [4]. Currently, autologous and allogenic adipose tissues represent a ubiquitous source of material for fat reconstructive therapies.…”
Section: Introductionmentioning
confidence: 99%